Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2016

Open Access 01-12-2016 | Research

Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran

Authors: Masoumeh Bagheri-Nesami, Alireza Rafiei, Gohar Eslami, Fatemeh Ahangarkani, Mohammad Sadegh Rezai, Attieh Nikkhah, Azin Hajalibeig

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2016

Login to get access

Abstract

Background

Device-associated nosocomial infections (DA-NIs), due to MDR Enterobacteriaceae, are a major threat to patient safety in ICUs. We investigated on Extended-spectrum β-lactamases (ESBL) producing Enterobacteriaceae and incidence of integrons in these bacteria isolated from ventilator-associated pneumonia (VAP) and catheter-associated urinary tract infections (CAUTIs) in 18 governmental hospitals in the north of Iran.

Methods

In this cross-section study, the antibiotic susceptibility test was performed using the MIC method; also, phenotypically detection of ESBL-producing bacteria was carried out by the double-disk synergy (DDS) test. Presence of ESBL-related genes and integron Classes 1 and 2 was evaluated by the PCR method.

Results

Out of a total of 205 patients with DA-NIs, Enterobacteriaceae were responsible for (72.68%) of infections. The most common DA-NIs caused by Enterobacteriaceae were VAP (77.18%), CAUTI (19.46%), and sepsis due to VAP (3.35%). The most frequently Enterobacteriaceae were; Klebsiella pneumoniae 75 (24; 32% ESBL positive), E. coli 69 (6; 8.69% ESBL positive) and Enterobacter spp. 5 (5; 100% ESBL positive). Distribution of ESBL-related genes was as follows: bla-SHV (94.3%), bla-CTX (48.6%), bla-VEB (22.9%) and bla-GES (17.14%). The incidence rate of integron class 1 and class 2 was (82.92%) and (2.9%) respectively. Eight types of ESBL-producing bacteria were observed.

Conclusions

Due to the fact that the emergence rate of ESBL Enterobacteriaceae is increasing in DA-NIs, co-incidence of different types of ESBL genes with integrons in 75–100% of strains in our study is alarming for clinicians and healthcare safety managers. Therefore, regional and local molecular level estimations of ESBLs that are agents of DA-NIs are critical for better management of empiric therapy, especially for patients in ICUs.
Appendix
Available only for authorised users
Literature
1.
Blot S, et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol. 2005;26(4):352–6.CrossRefPubMed
2.
3.
Heyland DK, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159(4):1249–56.CrossRefPubMed
4.
Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933–51.CrossRefPubMedPubMedCentral
5.
Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–66.CrossRefPubMed
6.
7.
Ploy M-C, et al. Integrons: an antibiotic resistance gene capture and expression system. Clin Chem Lab Med. 2000;38(6):483–7.CrossRefPubMed
8.
Machado E, et al. Preservation of integron types among Enterobacteriaceae producing extended-spectrum β-lactamases in a Spanish hospital over a 15-year period (1988 to 2003). Antimicrob Agents Chemother. 2007;51(6):2201–4.CrossRefPubMedPubMedCentral
9.
Collee J, Miles R, Watt B. Tests for identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, editors. Practical medical microbiology. 14th ed. Edinburgh: Churchill Livingstone; 1996. p. 131–50.
10.
Koneman E, Allen S, Janda W, Schreckenberger R, Winn W. Introduction to microbiology. In: Koneman EW, Alien SD, Janda WM, Schreckenberger RC, Winn W, editors. Part II; Guidelines for collection, transport, processing, analysis, and reporting of cultures from specific specimen sources, Color atlasand textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippincott; 1997. p. 121–70.
11.
Jarlier V, et al. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867–78.CrossRefPubMed
12.
Rezai M-s, et al. Multidrug resistance pattern of bacterial agents isolated from patient with chronic sinusitis. Caspian J Intern Med. 2016;7(2):114–9.PubMedPubMedCentral
13.
Afhami S, et al. Ventilator-associated pneumonia in a teaching hospital in Tehran and use of the Iranian Nosocomial Infections Surveillance Software. East Mediterr Health J. 2013;19(10):883.PubMed
14.
Askarian M, et al. Incidence of urinary tract and bloodstream infections in Ghotbeddin Burn Center, Shiraz 2000–2001. Burns. 2003;29(5):455–9.CrossRefPubMed
15.
Jahani-Sherafat S, et al. Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: findings from the International Nocosomial Infection Control Consortium (INICC). J Infect Public Health. 2015;8(6):553–61.CrossRefPubMed
16.
Rosenthal VD, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145(8):582–91.CrossRefPubMed
17.
Salomao R, et al. Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica. 2008;24(3):195–202.CrossRefPubMed
18.
Behzadnia S, et al. Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of Iran. Iran Red Crescent Med J. 2014;16(2):e14562. doi:10.​5812/​ircmj.​14562.
19.
Saffar M, et al. Antibacterial susceptibility of uropathogens in 3 hospitals, Sari, Islamic Republic of Iran, 2002–2003. 2008.
20.
Rezai MS et al. Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran. Biomed Res Int. 2015;2015. doi:10.​1155/​2015/​309478.
21.
Khorshidi A, et al. Prevalence of TEM1 & SHV1 genes in Kelebsiella pneumoniea with ESBL. J Mil Med. 2009;11(3):149–53.
22.
Khosravi AD, Hoveizavi H, Mehdinejad M. Prevalence of Klebsiella pneumoniae Encoding Genes for Ctx-M-1, Tem-1 and Shv-1 Extended-Spectrum Beta Lactamases (ESBL) Enzymes in Clinical Specimens. Jundishapur J Microbiol. 2013;6(10):e8256. doi:10.​5812/​jjm.​8256.
23.
Behrooozi A, Rahbar M, Jalil V. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res. 2010;4(9):881–4.
24.
Feizabadi MM, et al. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries. 2010;4(10):609–15.CrossRefPubMed
25.
Corkill JE, Anson JJ, Hart CA. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother. 2005;56(6):1115–7.CrossRefPubMed
26.
Jones LA, et al. The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 2005;49(2):794–7.CrossRefPubMedPubMedCentral
27.
Novais Â, et al. Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups. Antimicrob Agents Chemother. 2006;50(8):2741–50.CrossRefPubMedPubMedCentral
28.
Sidjabat HE, et al. Identification of blaCMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J Antimicrob Chemother. 2006;57(5):840–8.CrossRefPubMed
Metadata
Title
Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran
Authors
Masoumeh Bagheri-Nesami
Alireza Rafiei
Gohar Eslami
Fatemeh Ahangarkani
Mohammad Sadegh Rezai
Attieh Nikkhah
Azin Hajalibeig
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2016
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-016-0143-2

Other articles of this Issue 1/2016

Antimicrobial Resistance & Infection Control 1/2016 Go to the issue

Research

Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey

Research

Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?

Research

New dominant spa type t2741 in livestock-associated MRSA (CC398-MRSA-V) in Finnish fattening pigs at slaughter

Research

Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species

Research

Tackling wicked problems in infection prevention and control: a guideline for co-creation with stakeholders

Research

Patterns of medication use and factors associated with antibiotic use among adult fever patients at Singapore primary care clinics
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits